Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07561125
PHASE2

Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and Below

Sponsor: International Peace Maternity and Child Health Hospital

View on ClinicalTrials.gov

Summary

It is intended to examine the short-term and long-term efficacy and safety of intravenous immunoglobulin(IVIG) for the bronchopulmonary dysplasia in preterms born at 28 weeks and below. Participants will received continuous infusion IVIG 1 g/kg/day for the first 2 days, 0.5 g/kg/day for next 3 days (total does 3.5 g/kg), repeatable if necessary.

Official title: The Short-term and Long-term Effects of IVIG for Bronchopulmonary Dysplasia in Preterm Infant Born at 28 Weeks and Below

Key Details

Gender

All

Age Range

1 Day - 10 Weeks

Study Type

INTERVENTIONAL

Enrollment

29

Start Date

2026-04-23

Completion Date

2029-09

Last Updated

2026-07-23

Healthy Volunteers

Yes

Interventions

DRUG

intravenous immunoglobulin

1 g/kg/day for the first 2 days, 0.5 g/kg/day for next 3 days (total does 3.5 g/kg), repeatable if necessary.

Locations (1)

International Peace Maternity and Child Health Hospital

Shanghai, China